The Board of Directors of BioLamina has announced the appointment of Veronica Byfield Sköld as the new Chief Executive Officer.
The appointment of a new CEO comes at a time of accelerated growth of BioLamina, which is currently expanding its manufacturing capacity fourfold in order to meet customer demand, the company states.
“The board and I are delighted to welcome Veronica as the new CEO of BioLamina. I am confident that she, given her strong commercial competence and knowledge of the life science industry, has the strategic and leadership skills necessary to realize BioLamina’s full potential,” says Sophie Hagströmer, Chairman of the Board of Directors and investment professional at Bure Equity.
Veronica Byfield Sköld
Veronica Byfield Sköld brings extensive experience from the broader healthcare and life science field, with a focus on strategy, business development and commercialization in highly regulated markets. She holds an MSc in Industrial Engineering and Business Management from The Royal Institute of Technology in Stockholm, Sweden, and spent the first years of her career at management consulting firm The Boston Consulting Group (BCG).
After that she has held several management positions in companies like Gambro (renal care and blood component technology), Elekta (radiation oncology, radiosurgery and neuroscience), and Permobil (advanced rehab), heading up activities within strategy, marketing, commercialization, and medical affairs across global organizations. Most recently Veronica spent four years as an investment partner at the Nordic healthcare investment firm Impilo. She has served as a Director of the Board of BioLamina since April 2021.
“I have been fascinated by the domain of cell therapy since my early years with Gambro, and it is exciting to see the current development across the field, with so many activities moving into clinical phase. The products BioLamina offers are key to support many of these efforts, and the strong demand we are experiencing is a great indication that customers across the globe are highly appreciative of the work the company is doing. Since joining the Board of Directors in early 2021, I have gradually got to know the market, company and team better, and I have seen the tremendous growth and all the opportunities that lay ahead of us. I am very excited to join this highly competent team and work jointly to advance the success of BioLamina and our customers,” says Veronica Byfield Sköld.
Photo ofVeronica Byfield Sköld: Patrick Degerman